NASDAQ:LFST
LifeStance Health Group, Inc.
LifeStance Health Group, Inc.'s revenue grew 13.9% in fiscal 2025 to $1.4B while operating margin rose to 1.7%. Free cash flow was $110.0M, 7.7% of revenue, and the diluted share count rose 3.2%.Summary generated from LifeStance Health Group, Inc.'s SEC filings. Latest annual report filed Feb 25, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$1.4B
Revenue growth+13.9%
Revenue, 5-yr CAGR+46.3%
Gross marginn/a
Operating margin1.7%
Net margin0.7%
ROIC1.2%
Return on equity0.7%
Debt / equity0.19
Free cash flow$110.0M
FCF margin7.7%
Share count change+3.2%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 668 | 860 | 1,056 | 1,251 | 1,424 |
| Operating income | −286 | −210 | −189 | −32 | 24 |
| Net income | −307 | −216 | −186 | −57 | 10 |
| Free cash flow | −85 | −26 | −57 | 86 | 110 |
Recent filings
- 4Insider transaction report
Sep 24, 2026 - 4Insider transaction report
Sep 15, 2026 - 8-KOther events
Sep 11, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 6, 2026 - 8-KResults of operations and financial condition
Aug 6, 2026 - 8-KDirector or officer change
Jul 7, 2026 - 8-KResults of a shareholder vote
Jun 4, 2026 - 8-KOther events
May 12, 2026